Evidence map›Paper›PMID 39169943›Full record

ArticleFrontiers in oncology2024

Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature.

Nalini Srinivas, Lukas Peiffer, Kai Horny, Kuan Cheok Lei, Terkild B Buus, Linda Kubat, Meng Luo, Menghong Yin, Ivelina Spassova, Antje Sucker and 7 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Epigenetic dysregulation in mycosis fungoides and sézary syndrome.Frontiers in cell and developmental biology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nalini Srinivas *Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Lukas Peiffer *Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Kai HornyTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Kuan Cheok LeiTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Terkild B BuusLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Linda KubatTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Meng LuoTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Menghong YinTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Ivelina SpassovaTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.
Antje SuckerDepartment of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.
Farnoush FarahpourBioinformatics and Computational Biophysics, University Duisburg-Essen, and Group of Molecular Cell Biology, Institute for Cell Biology (Cancer Research), University Hospital Essen, Essen, Germany.
Jan KehrmannInstitute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Selma UgurelDepartment of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.
Elisabeth LivingstoneDepartment of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.
Thilo GambichlerDepartment of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Niels ØdumLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Jürgen C BeckerTranslational Skin Cancer Research, German Cancer Consortium (DKTK), University Medicine Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL). Comprehensive analysis of MF cells Methods: To overcome this limitation, we performed combined single-cell RNA (scRNAseq) and T-cell receptor TCR sequencing (scTCRseq) of skin lesions of cutaneous MF lesions from 12 patients. A sufficient quantity of living T cells was obtained from 9 patients, but 2 had to be excluded due to unclear diagnoses (coexisting CLL or revision to a fixed toxic drug eruption). Results: From the remaining patients we established single-cell mRNA expression profiles and the corresponding TCR repertoire of 18,630 T cells. TCR clonality unequivocally identified 13,592 malignant T cells. Reactive T cells of all patients clustered together, while malignant cells of each patient formed a unique cluster expressing genes typical of naive/memory, such as Conclusions: Combined scRNAseq and scTCRseq not only allows unambiguous identification of MF cells, but also revealed marked heterogeneity between and within patients with unexpected functional phenotypes. While the correlation between mRNA and protein abundance was limited with respect to established MF markers, we were able to identify a single-cell gene expression signature that distinguishes malignant from reactive T cells.

Indexed as

CTCLgene signatureheterogeneitymalignant T cellssingle-cell RNA sequencingTCR sequencing

Identifiers

PMID39169943
PMCPMC11337020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.